Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned favorably within the biopharmaceutical sector, leveraging its innovative antibody technologies to address infectious diseases with pandemic potential, particularly COVID-19. The company is developing advanced product candidates such as ADG20 and VYD222, which exhibit superior antiviral potency and broad neutralization capabilities, anticipated to enhance their marketability in a projected $3-4 billion global market by 2030. Furthermore, promising results from Phase 1/2 trials indicate a robust safety profile, instilling confidence in the efficacy and longevity of Invivyd’s products, which could serve as significant drivers of long-term growth.

Bears say

Invivyd Inc, while promoting innovative antibody solutions aimed at enhancing immune response against viruses like COVID-19, faces significant challenges regarding the efficacy and public acceptance of existing vaccines. The company's emphasis on the limitations of current vaccination approaches, including waning antibody responses and public hesitancy, illustrates a potential barrier to market penetration for its products. Despite a projected $4 billion in COVID vaccine revenue highlighting the total addressable market, this figure does not mitigate concerns regarding Invivyd's ability to distinguish its offerings or achieve sustained demand in a competitive and evolving landscape.

Invivyd Inc (IVVD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Dec 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.